DRIEHAUS CAPITAL MANAGEMENT LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 145 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q3 2022$9,507,000
+215.7%
1,633,541
+170.2%
0.14%
+41.2%
Q2 2018$3,011,000
+33.1%
604,596
+4.2%
0.10%
+27.5%
Q1 2018$2,263,000–580,246–0.08%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q4 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders